Varilrix 0.5 ml Powder for solution and injection.
PDF Leaflet Revision Date: 21 June 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Active immunisation against varicella in healthy infants, children, adolescents, and high-risk patients.
Dosage (summary)
0.5 ml for healthy subjects; 2 doses for ages 9 months to 12 years and for 13 years and above, with a minimum interval of 4 weeks.
Special Populations
- Immunocompromised patients
- Patients with chronic diseases
- High-risk patients
Pregnancy & Breastfeeding
Contraindicated in pregnancy; avoid pregnancy for 1 month post-immunisation; not advised during breastfeeding.
Key Drug Interactions
- Avoid salicylates for 6 weeks post-vaccination
- Delay vaccination after immune globulin or blood transfusion for 3 months
Contraindications
- Severe immunodeficiency
- Hypersensitivity to neomycin or components
- Pregnancy
Common side effects
- Pain at injection site
- Fever
- Rash
- Lymphadenopathy
Counselling Points
- Inform about potential mild varicella breakthrough cases
- Advise on injection site care
- Discuss the importance of completing the vaccination schedule
Serious warnings
- Postpone in acute severe febrile illness
- Monitor for anaphylactic reactions
- Avoid contact with immunocompromised individuals for 14 days post-vaccination
Important Disclaimer
The Varilrix 0.5 ml Powder for solution and injection. professional information leaflet below is the property of Glaxosmithkline South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
